COVID 19: a completely unique CORONAVIRUS AND a completely unique CHALLENGE FOR CRITICAL CARE

Sayali Ramesh thakekar; Priyanka Santosh Waje

COVID 19: a completely unique CORONAVIRUS AND a completely unique CHALLENGE FOR CRITICAL CARE

Authors: Sayali Ramesh thakekar, Priyanka Santosh Waje

Unique Paper ID: 149735
Volume: 7
Issue: 1
PageNo: 401-405

Keywords: corona virus covid-19 sars-cov

Abstract:
Coronaviruses (COV) are an excellent family of viruses that cause ailments starting from the cold to more severe sicknesses like Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).2-14 days represents the present official estimated range for the novel coronavirus COVID-19.The World Health Organization (WHO) declared the 2019-20 coronavirus outbreak an epidemic and a Public Health Emergency of International Concern (PHEIC).1 The spread of coronavirus disease 2019 (COVID-19) is becoming unstoppable and has already reached the required epidemiological criteria for it to be declared an epidemic ,having infected quite 100 000 people in 100 countries.2 COVID 19 virus may be a new member of the betacoronavirus genus and is closely associated with several bat coronaviruses Compared to SARS-CoV and MERS-CoV, COVID-19 virus exhibits faster human-to-human transmission, thus resulting in the WHO declaration of a world-wide public health emergency.3 The impact of a plague depends on the amount of persons infected, the infection's transmissibility, and therefore the spectrum of clinical severity.4 On the idea of "alarming levels of spread and severity, and by the alarming levels of inaction", on March 11, 2020, the Director General of WHO characterised the COVID-19 situation as an epidemic

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 7
Issue: 1
PageNo: 401-405

COVID 19: a completely unique CORONAVIRUS AND a completely unique CHALLENGE FOR CRITICAL CARE

Available:https://ijirt.org/Article?manuscript=149735

11 Jan, 2022

EVALUATION OF MARKETED EFFERVESCENT TABLETS

13 Oct, 2021

Bacterial Biofilm Inhibitor

02 Aug, 2021

The risk of death caused by the use of norepinephrine-resistant hypotension in the condition of septic shock in a patient

02 Aug, 2021

COMPUTER AIDED DRUG DESIGN (CADD)

29 Jul, 2021

Impact : Of Second Wave Covid-19 In world

29 Jul, 2021

The use of milrinone for curing a chronic heart failure

26 Jul, 2021

Leprosy Disease review

20 Jul, 2021

Transdermal Drug Delivery System

13 Jul, 2021

IBUPROFEN: AN OVERVIEW

13 Jul, 2021

CHEMOTHERAPY FOR BREAST CANCER

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry